Literature DB >> 19047657

Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.

Paul A Aeed1, Casey L Young, Marek M Nagiec, Ake P Elhammer.   

Abstract

By using a detergent-washed membrane preparation, the interaction of the fungal natural product inhibitor aureobasidin A (AbA) with inositol phosphorylceramide synthase (IPC synthase) was studied by kinetic analysis of wild-type and mutant enzyme-catalyzed reactions. AbA inhibited the wild-type enzyme from both Candida albicans and Saccharomyces cerevisiae in an irreversible, time-dependent manner, with apparent K(i) values of 183 and 234 pM, respectively. Three synthetic chemistry-derived AbA derivatives, PHA-533179, PHA-556655, and PHA-556656, had affinities 4 to 5 orders of magnitude lower and were reversible inhibitors that competed with the donor substrate phosphatidylinositol (PI). AbA was a reversible, apparently noncompetitive inhibitor, with a K(i) of 1.4 microM, of the IPC synthase from an AbA-resistant S. cerevisiae mutant. The K(m) values for both substrates (ceramide and PI) were similar when they interacted with the mutant and the wild-type enzymes. By contrast, the V(max) for the mutant enzyme was less than 10% of that for the wild-type enzyme. A comparison of the results obtained with AbA with those obtained with two other natural products inhibitors, rustmicin and khafrefungin, revealed that while rustmicin appeared to be a reversible, noncompetitive inhibitor of the wild-type enzyme, with a K(i) of 16.0 nM, khafrefungin had the kinetic properties of a time-dependent inhibitor and an apparent K(i) of 0.43 nM. An evaluation of the efficiencies of these compounds as inhibitors of the mutant enzyme revealed for both a drop in the apparent affinity for the enzyme of more than 2 orders of magnitude.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047657      PMCID: PMC2630602          DOI: 10.1128/AAC.00633-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Isolation and characterization of novel inhibitors of sphingolipid synthesis: australifungin, viridiofungins, rustmicin, and khafrefungin.

Authors:  S M Mandala; G H Harris
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

Review 2.  Structure and function of sphingolipid- and cholesterol-rich membrane rafts.

Authors:  D A Brown; E London
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

3.  Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans.

Authors:  C Luberto; D L Toffaletti; E A Wills; S C Tucker; A Casadevall; J R Perfect; Y A Hannun; M Del Poeta
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

4.  Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species.

Authors:  W Zhong; M W Jeffries; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 5.  Brave little yeast, please guide us to thebes: sphingolipid function in S. cerevisiae.

Authors:  R Schneiter
Journal:  Bioessays       Date:  1999-12       Impact factor: 4.345

6.  Inositol phosphorylceramide synthase is located in the Golgi apparatus of Saccharomyces cerevisiae.

Authors:  T P Levine; C A Wiggins; S Munro
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

7.  C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p.

Authors:  I Guillas; P A Kirchman; R Chuard; M Pfefferli; J C Jiang; S M Jazwinski; A Conzelmann
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

8.  Formation and remodeling of inositolphosphoceramide during differentiation of Trypanosoma cruzi from trypomastigote to amastigote.

Authors:  Maria Laura Salto; Laura E Bertello; Mauricio Vieira; Roberto Docampo; Silvia N J Moreno; Rosa M de Lederkremer
Journal:  Eukaryot Cell       Date:  2003-08

9.  Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity.

Authors:  Paul W Denny; David Goulding; Michael A J Ferguson; Deborah F Smith
Journal:  Mol Microbiol       Date:  2004-04       Impact factor: 3.501

10.  Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast.

Authors:  M Bagnat; S Keränen; A Shevchenko; A Shevchenko; K Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  15 in total

Review 1.  The antifungal pipeline: a reality check.

Authors:  John R Perfect
Journal:  Nat Rev Drug Discov       Date:  2017-05-12       Impact factor: 84.694

Review 2.  The Future of Antifungal Drug Therapy: Novel Compounds and Targets.

Authors:  Caroline Mota Fernandes; Deveney Dasilva; Krupanandan Haranahalli; J Brian McCarthy; John Mallamo; Iwao Ojima; Maurizio Del Poeta
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

3.  Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation.

Authors:  Ali Abdul Lattif; Pranab K Mukherjee; Jyotsna Chandra; Mary R Roth; Ruth Welti; Mahmoud Rouabhia; Mahmoud A Ghannoum
Journal:  Microbiology (Reading)       Date:  2011-09-08       Impact factor: 2.777

Review 4.  Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections.

Authors:  Cheng Zhen; Hui Lu; Yuanying Jiang
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

Review 5.  Sphingolipids as targets for treatment of fungal infections.

Authors:  Rodrigo Rollin-Pinheiro; Ashutosh Singh; Eliana Barreto-Bergter; Maurizio Del Poeta
Journal:  Future Med Chem       Date:  2016-08-09       Impact factor: 3.808

6.  Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicans.

Authors:  Saif Hameed; Sanjiveeni Dhamgaye; Ashutosh Singh; Shyamal K Goswami; Rajendra Prasad
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

7.  Sphingolipid and ceramide homeostasis: potential therapeutic targets.

Authors:  Simon A Young; John G Mina; Paul W Denny; Terry K Smith
Journal:  Biochem Res Int       Date:  2012-02-09

8.  The capacity of Aspergillus niger to sense and respond to cell wall stress requires at least three transcription factors: RlmA, MsnA and CrzA.

Authors:  Markus Rm Fiedler; Annett Lorenz; Benjamin M Nitsche; Cees Amjj van den Hondel; Arthur Fj Ram; Vera Meyer
Journal:  Fungal Biol Biotechnol       Date:  2014-12-01

9.  Sphingolipids activate the endoplasmic reticulum stress surveillance pathway.

Authors:  Francisco Piña; Fumi Yagisawa; Keisuke Obara; J D Gregerson; Akio Kihara; Maho Niwa
Journal:  J Cell Biol       Date:  2018-01-09       Impact factor: 10.539

10.  The antifungal Aureobasidin A and an analogue are active against the protozoan parasite Toxoplasma gondii but do not inhibit sphingolipid biosynthesis.

Authors:  A Q I Alqaisi; A J Mbekeani; M Bassas Llorens; A P Elhammer; P W Denny
Journal:  Parasitology       Date:  2017-05-10       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.